Dermira (DERM) Could Rally to $15 or More Following Data - Mizuho Securities
Mizuho Securities analyst Irina Koffler said Dermira (NASDAQ: DERM) shares could rally to $15 or higher following positive Lebri data.Koffler ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
